References
- Iwasaki Y. Creutzfeldt-Jakob disease. Neuropathology. 2017;37:174–188.
- Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999;46:224–233.
- Hayashi Y, Iwasaki Y, Waza M, et al. Clinicopathological findings of an MM2-corticyal-type sporadic Creutzfeldt-Jakob disease patient with cortical blindness during a course of glaucoma and age-related macular degeneration. Prion. 2019;13:124–131.
- Biadri S, Capellari S, Ladogana A, et al. Revisiting the Heidenhain variant of Creutzfeldt-Jakob disease: evidence for prion type variability influencing clinical course and laboratory findings. J Alzheimers Dis. 2016;50:465–476.
- Hayashi Y, Yamada M, Kimura A, et al. Clinical findings of a probable case of MM2-cortical-type sporadic Creutzfeldt-Jakob disease with antibodies to anti-N-terminus of α-enolase. Prion. 2017;11:454–464.
- Hayashi Y, Iwasaki Y, Waza M, et al. Clinicopathological findings of a long-term survivor of V180I genetic Creutzfeldt-Jakob disease. Prion. 2020;14:109–117.
- Iwasaki Y, Akagi A, Mimuro M, et al. Factors influencing the survival period in Japanese patients with sporadic Creutzfeldt-Jakob disease. J Neurol Sci. 2015;357:63–68.
- Hamaguchi T, Sanjo N, Ae R, et al. MM2-type sporadic Creutzfeldt-Jakob disease: new diagnostic criteria for MM2-cortical type. J Neurol Neurosurg Psychiatry. 2020;91:1158–1165.
- Master CL, Harris JO, Gajudesk DC, et al. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol. 1979;5:177–188.
- Atarashi R, Satoh K, Sano K, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med. 2011;17:165–178.
- Yoneda M, Fujii A, Ito A, et al. High prevalence of serum autoantibodies against the amino terminal of alpha-enolase in Hashimoto’s encephalitis. J Neuroimmunol. 2007;185:195–200.
- Kunieda K, Ohno T, Fujishima I, et al. Reliability and validity of a tool to measure the severity of dysphagia: the food intake LEVEL scale. J Pain Symptom Manage. 2013;46:201–206.
- Miyaji H, Umezaki T, Adachi K, et al. Videofluoroscopic assessment of pharyngeal stage delay reflects pathophysiology after brain infarction. Laryngoscope. 2012;122:2793–2799.
- Hayashi Y, Yoshikura N, Takekoshi A, et al. Preserved regional cerebral blood flow in the occipital cortices, brainstem, and cerebellum of patients with V180I-129M genetic Creutzfeldt-Jakob disease in serial SPECT studies. J Neurol Sci. 2016;370:145–151.
- Lang IM. Brain stem control of the phases of swallowing. Dysphagia. 2009;24:333–348.
- Kunieda K, Hayashi Y, Yamada M, et al. Serial evaluation of swallowing function in a long-term survivor of V180I genetic Creutzfeldt-Jakob disease. Prion. 2020;14:180–184.